Ask AI
ProCE Banner Activity

My Take on New Advances in CLL From ASCO 2019

Clinical Thought
Are you aware of some of the latest clinical data in CLL? In this commentary I will discuss 3 key studies on venetoclax acalabrutinib and lisocabtagene maraleucel in CLL that were presented at ASCO 2019.

Released: June 27, 2019

Expiration: June 25, 2020

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Pharmacyclics AbbVie

Verastem Oncology

Partners

CLL Society

ProCE Banner